Artificial Intelligence Technology Solutions Inc
Change company Symbol lookup
Select an option...
AITX Artificial Intelligence Technology Solutions Inc
DPXCF DelphX Capital Markets Inc
HROWL HARROW HEALTH 8 625 SNR NTS
MLTX MoonLake Immunotherapeutics
TRTN Triton International Ltd
PAYA Paya Holdings Inc
MA Mastercard Inc
MWRK MetaWorks Platforms Inc
NSRGY Nestle SA
MIN MFS? Intermediate Income Fund
Go

Company profile

Artificial Intelligence Technology Solutions Inc. is engaged in the delivery of artificial intelligence (AI) and robotic solutions for operational, security, and monitoring needs. The Company is focused on applying advanced AI-driven technologies, paired with multi-use hardware, and supported by custom software and cloud services, to intelligently automate and integrate a range of high-frequency security, concierge, and operational tasks. It owns and operates three wholly owned subsidiaries, which are Robotic Assistance Devices, Inc. (RAD I), Robotic Assistance Devices Group, Inc. (RAD G) and Robotic Assistance Devices Mobile, Inc. (RAD M). RAD I own the intellectual property related to RADSoC, RAD Mobile SOC, RADGuard, and their core operating architecture. RAD G is focused on the development of advanced software and electronics solutions. RAD M is focused on the development of autonomous mobile devices, both ground-based, and airborne. Its solutions are suited to various industries.

Closing Price
$0.0082
Day's Change
0.0003 (3.82%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0082
Day's Low
0.0076
Volume
(Light)
Volume:
23,766,630

10-day average volume:
34,361,630
23,766,630

AMGEN ANNOUNCES WEBCAST OF 2022 EVERCORE ISI HEALTHCARE CONFERENCE

4:00 pm ET November 23, 2022 (PR Newswire) Print

Amgen (NASDAQ:AMGN) will present at the Evercore ISI HealthCONx Conference at 11:20 a.m. ET on Tuesday, November 29, 2022. David M. Reese, M.D., executive vice president of Research and Development at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About AmgenAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to beone ofthe world'sleadingindependent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Amgenis one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2022, Amgen was named one of the "World's Best Employers" by Forbes and one of "America's 100 Most Sustainable Companies" by Barron's.

For more information, visitAmgen.comand follow us onTwitter, LinkedIn, Instagram, TikTokand YouTube.

CONTACT: Amgen, Thousand OaksMegan Fox, 805-447-1423 (media)Jessica Akopyan, 805-447-0974 (media)Arvind Sood, 805-447-1060 (investors)

https://mma.prnewswire.com/media/152881/amgen_logo.jpg

https://c212.net/c/img/favicon.png?sn=LA45312&sd=2022-11-23

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2022-evercore-isi-healthcare-conference-301686457.html

SOURCE Amgen

https://rt.newswire.ca/rt.gif?NewsItemId=LA45312&Transmission_Id=202211231600PR_NEWS_USPR_____LA45312&DateId=20221123

comtex tracking

COMTEX_419565666/1005/2022-11-23T16:00:08

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.